We have a very important report coming out from the FDA, an amendment that I authored in the FDA Safety and Innovation Act that we passed, that is going to require an action plan for more participation of women in drug clinical trials, because women are different than men and have different reactions.
Hatch emphasizes the need for women's participation in drug trials due to differing health responses.
Share
More from Orrin Hatch
It is important to support the ability of retirement plans to honor commitments made to working Americans.
I am grateful to my colleagues and especially my colleague from Louisiana for his kind remarks on the floor of the U.S. Senate. It means so much to me. I want him to know that. I want the others to realize how much I appreciated their…
on May 14, 2018, the Supreme Court in Murphy v. NCAA, 138 S. Ct. 1461, 2018, struck down the Federal prohibition of State-authorized sports wagering schemes. I was one of four original authors of that prohibition, the Professional and…
Other voices in this conversation
